Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "complement factor H-related family member pseudogene CFHR" is a pseudogene, meaning it is a nonfunctional DNA sequence similar in structure to the family of complement factor H-related (CFHR) genes. Pseudogenes typically arise from duplication or mutation of functional genes and lose the ability to encode a functional protein product[4]. While some pseudogenes may have regulatory RNA roles or produce non-functional peptides, the CFHR pseudogene is not known to have direct biological or clinical significance, nor is it an established drug target[2][3][4]. The functional CFHR1-5 genes, but not the pseudogenes, are implicated in renal and complement disorders when altered, especially through hybrid gene formation with CFH[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement factor H-related family member pseudogene (CFHR pseudogene).